ALS

ALS neurons brain synapses
Pharma

Amylyx to pull failed ALS drug from market, cut 70% of staff

Amylyx is pulling the ALS drug Relyvrio from the U.S. and Canadian markets after a confirmatory trial failure.
Angus Liu Apr 4, 2024 10:06am
visual of drugs being inspected by a magnifying glass

Amylyx's ALS drug finally scores a positive vote from FDA panel

Sep 8, 2022 8:16am
US FDA

Amylyx's ALS drug faces tough FDA scrutiny—again

Sep 6, 2022 4:38pm
FDA Building 2

ALS Association pushes for FDA approval of pending Amylyx drug

Sep 15, 2021 11:11am
US Capitol Building

New Alzheimer's drug gives price reformers their poster child

Jun 10, 2021 10:29am
Alexion

JPM: Alexion to take next-gen Ultomiris into tough ALS study

Jan 14, 2020 5:00pm